|
1. BIOLOGIE
|
|
|
|
|
1.1 BIOLOGIE - GÈNES
|
|
|
|
2. ETIOLOGIE
|
|
|
|
2.6 ETIOLOGIE - ENVIRONNEMENT
|
|
|
|
3.1 PRÉVENTION - TABAC
|
|
|
|
3.2 PRÉVENTION - OBÉSITÉ
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
Getting at the roots rather than pruning the branches of overdiagnosis [BMJ]
|
|
|
|
|
|
As any arborist knows, it is easier to train a tree early in its growth rather than attempting heavy pruning after the tree is well established. Rather than pruning one branch at a time, we need to address the roots of overdiagnosis by introducing probability-based medicine throughout medical training.
|
|
|
|
|
|
|
|
4.10 DÉP., DIAG. & PRONO. - FDA, EMA, NICE,...
|
|
|
|
4.7 DÉP., DIAG. & PRONO. - COL DE L'UTÉRUS
|
|
|
Screening service in 'meltdown' as more women attend smears [The Guardian]
|
|
|
|
|
|
The crisis has been triggered by a surge in numbers of women attending smear tests following a government public awareness campaign launched earlier this month. The campaign coincides with an exodus of biomedical scientists due to a restructuring process that will reduce nearly 50 hospital screening laboratories to nine this summer.
|
|
|
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5. TRAITEMENTS
|
|
|
Darolutamide Delays the Spread of Some Prostate Cancers [NCI]
|
|
|
|
|
|
The ARAMIS trial, which was sponsored by Bayer and Orion Corporation—the co-developers of darolutamide—included men whose prostate-specific antigen (PSA) levels were rising at a rate that has been associated with an increased risk of metastasis and death in previous studies.
|
|
|
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
|
|
5.12.8 IMMUNOTHÉRAPIES - ECONOMIE
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.1 PHARMA - PARTENARIATS
|
|
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
6.11 PATIENTS
|
|
|
|
6.4 MÉDICO-ÉCO
|
|
|
|
6.7.1 IA/BIOINFORMATIQUE
|
|
|
TGen Adjusting to New Realities of Bioinformatics for Precision Medicine [Genome Web]
|
|
|
|
|
|
IT has become a commodity, but bioinformaticians remain in high demand. The nature of biomedical research has changed, too. "When I started, lab people came in with white coats and pipettes," Lowey said. "Now, they may have the white coats or they may not, but they're carrying around laptops. Everything has moved into in silico modeling," Lowey said.
|
|
|
|
|
|
|